Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FXN63
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,818
Award facts
- Contract value 100% obligated
- $25,817.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kisqali 400 mg daily dose tablets (42-count packages) with a ceiling value of $25,817.94. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills delivery orders for the Defense Logistics Agency across a broad spectrum of pharmaceutical products supporting military and veteran healthcare systems. Kisqali is a hormone receptor-positive breast cancer treatment, reflecting the company's role in supplying specialized oncology medications alongside its portfolio of generic drugs, vaccines, antibiotics, and other medical commodities. The company's demonstrated capability to compete successfully and deliver products across multiple therapeutic domains, combined with its substantial prime vendor contract with DLA, positions it as a key supplier in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FXN63?
SPE2DB25FXN63 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXN63 worth?
The government has obligated $25,818 on SPE2DB25FXN63.
Is contract SPE2DB25FXN63 an order under another contract?
Yes. SPE2DB25FXN63 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXN63 competed?
The extent of competition for SPE2DB25FXN63 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award